Indegene Limited Stock

Equities

INDGN

INE065X01017

Business Support Services

Market Closed - NSE India S.E. 07:43:54 2024-06-14 EDT 5-day change 1st Jan Change
585.5 INR -2.44% Intraday chart for Indegene Limited +7.81% 0.00%

Financials

Sales 2022 16.65B 199M 274M Sales 2023 23.06B 276M 379M Capitalization 130B 1.56B 2.14B
Net income 2022 1.65B 19.73M 27.09M Net income 2023 2.66B 31.86M 43.75M EV / Sales 2022 * -
Net cash position 2022 * - 0 0 Net cash position 2023 * - 0 0 EV / Sales 2023 * -
P/E ratio 2022 *
-
P/E ratio 2023 *
-
Employees 5,181
Yield 2022 *
-
Yield 2023 *
-
Free-Float 30.12%
More Fundamentals * Assessed data
Dynamic Chart
1 day-2.44%
1 week+7.81%
Current month+12.41%
1 month+3.34%
More quotes
1 week
536.10
Extreme 536.1
616.95
1 month
470.10
Extreme 470.1
616.95
Current year
452.00
Extreme 452
660.00
1 year
452.00
Extreme 452
660.00
3 years
452.00
Extreme 452
660.00
5 years
452.00
Extreme 452
660.00
10 years
452.00
Extreme 452
660.00
More quotes
Indegene Limited is a life sciences commercialization company. It provides digital-led commercialization services for the life sciences industry, including biopharmaceutical, emerging biotech, and medical devices companies. The Company operates through four segments: Enterprise Medical Solutions, Enterprise Commercial Solutions, Omnichannel Activation, and Others. Its Enterprise Commercial Solutions segment primarily involve assisting life sciences companies with their digital marketing operations. Its Omnichannel Activation solutions segment help life sciences companies leverage a digital first approach for optimizing the last-mile promotion of biopharmaceutical products and medical devices to healthcare professionals across multiple channels. Under its Enterprise Medical Solutions segment, it establishes centers of excellence to consolidate large scale regulatory and medical operations for its clients. Others segment offers enterprise clinical solutions and consultancy services.
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
585.5
Average target price
-
Consensus